Annals of internal medicine
-
Editorial
The Moral Imperative to Include Pregnant Women in Clinical Trials of Interventions for COVID-19.
Although the number of clinical trials for patients with COVID-19 is increasing, many exclude pregnant women as participants or do not address pregnancy. This commentary discuss why pregnancy women should be included in clinical trials of interventions for COVID-19.
-
Obesity is a risk factor for pneumonia and acute respiratory distress syndrome. ⋯ National Institutes of Health.
-
Strategies to improve patients' tolerance of and adherence to statins may enhance the effectiveness of dyslipidemia treatment in those at risk for cardiovascular disease (CVD). ⋯ U.S. Department of Veterans Affairs.
-
Obesity, race/ethnicity, and other correlated characteristics have emerged as high-profile risk factors for adverse coronavirus disease 2019 (COVID-19)-associated outcomes, yet studies have not adequately disentangled their effects. ⋯ Roche-Genentech.